Heart failure

Acute coronary syndrome: risk factors, diagnosis and treatment

This overview describes the different management options for acute coronary syndrome and how pharmacists can support patients with the condition.…

SGLT-2 inhibitors reduce heart failure risk across patient groups

Sodium–glucose cotransporter 2 inhibitors are associated with a reduced risk of heart failure compared with dipeptidyl peptidase 4 inhibitors, even in people without a history of cardiovascular disease, a study published in The BMJ has shown.…

Heart failure, older people and frailty

Diagnosis of heart failure and frailty can often be masked by other long-term conditions, making the delivery of treatment goals complicated.…

Room for improvement in UK heart failure care, researchers find

National reporting and incentive schemes, such as the Quality and Outcomes Framework, have not prevented suboptimal management of heart failure in the UK, research published in PLoS Medicine has concluded.…

Diuretic withdrawal appears safe in patients with stable chronic heart failure, trial shows

Patients who have chronic but stable heart failure should have their diuretic use reconsidered, researchers have suggested.…

Androgen deprivation therapy ‘increases heart failure risk’

Patients with prostate cancer treated with androgen deprivation therapy were 72% more likely to experience heart failure than those unexposed to the therapy, a study has shown.…

Pathophysiology and management of heart failure

Ensuring patients are optimised on maximum tolerated doses of medicines in heart failure with reduced ejection fraction is essential in minimising the burden of the condition.…

Supported content

Painkiller linked to increased risk of heart problems

More clear warnings should be given about the risks of diclofenac, say researchers who found a higher risk of heart attack and stroke associated with its use.…

Aspirin lowers risk of death in people with concomitant heart failure and diabetes

Aspirin reduces the risk of all-cause death or hospitalisation for heart failure in patients with concomitant type 2 diabetes and heart failure but increases the risk of non-fatal heart attack or stroke.…

ADT increases some cardiovascular risks in men with localised prostate cancer

A study finds that the use of androgen deprivation therapy to treat prostate cancer is associated with a heightened risk of developing cardiovascular disease and recommends closer cardiac monitoring during treatment…